These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 23702781)
1. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781 [TBL] [Abstract][Full Text] [Related]
2. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Li Q; Laumonnier Y; Syrovets T; Simmet T Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234 [TBL] [Abstract][Full Text] [Related]
3. T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration. Dohlman TH; Ding J; Dana R; Chauhan SK Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1330-1336. PubMed ID: 28241321 [TBL] [Abstract][Full Text] [Related]
4. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues. Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618 [TBL] [Abstract][Full Text] [Related]
5. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253 [TBL] [Abstract][Full Text] [Related]
7. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Chen Y; Chauhan SK; Lee HS; Stevenson W; Schaumburg CS; Sadrai Z; Saban DR; Kodati S; Stern ME; Dana R Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2457-64. PubMed ID: 23482465 [TBL] [Abstract][Full Text] [Related]
8. Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease. Coursey TG; Gandhi NB; Volpe EA; Pflugfelder SC; de Paiva CS PLoS One; 2013; 8(11):e78508. PubMed ID: 24223818 [TBL] [Abstract][Full Text] [Related]
9. CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. Kodati S; Chauhan SK; Chen Y; Dohlman TH; Karimian P; Saban D; Dana R Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5871-7. PubMed ID: 25139737 [TBL] [Abstract][Full Text] [Related]
10. Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway. Yu Q; Lou XM; He Y PLoS One; 2015; 10(3):e0120855. PubMed ID: 25768730 [TBL] [Abstract][Full Text] [Related]
11. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110 [TBL] [Abstract][Full Text] [Related]
13. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury. González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403 [TBL] [Abstract][Full Text] [Related]
14. Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases. Koga T; Otomo K; Mizui M; Yoshida N; Umeda M; Ichinose K; Kawakami A; Tsokos GC Arthritis Rheumatol; 2016 Aug; 68(8):1981-8. PubMed ID: 26945541 [TBL] [Abstract][Full Text] [Related]
15. The RORγt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients. Kaneko S; Kondo Y; Yokosawa M; Furuyama K; Segawa S; Tsuboi H; Kanamori A; Matsumoto I; Yamazaki M; Sumida T Mod Rheumatol; 2018 Sep; 28(5):814-825. PubMed ID: 29251019 [TBL] [Abstract][Full Text] [Related]
16. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Meitei HT; Jadhav N; Lal G Autoimmun Rev; 2021 Jul; 20(7):102846. PubMed ID: 33971346 [TBL] [Abstract][Full Text] [Related]
17. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation. Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851 [TBL] [Abstract][Full Text] [Related]
18. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Wang C; Kang SG; Lee J; Sun Z; Kim CH Mucosal Immunol; 2009 Mar; 2(2):173-83. PubMed ID: 19129757 [TBL] [Abstract][Full Text] [Related]
19. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Shirane J; Nakayama T; Nagakubo D; Izawa D; Hieshima K; Shimomura Y; Yoshie O Curr Eye Res; 2004 May; 28(5):297-306. PubMed ID: 15287366 [TBL] [Abstract][Full Text] [Related]
20. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]